Kim Wanlim, Han Ilkyu, Lee Jong S, Cho Hwan S, Park Jong W, Kim Han-Soo
Department of Orthopaedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea.
Department of Orthopaedic Surgery, Seoul National University Hospital, Seoul, Korea.
J Surg Oncol. 2018 May;117(6):1223-1231. doi: 10.1002/jso.24963. Epub 2018 Feb 6.
Prognostic factors predictive of postmetastasis survival (PMS) in metastatic osteosarcoma are poorly understood. Our aims were to evaluate PMS in patients with high-grade osteosarcoma in extremities, and to identify prognostic factors related to PMS.
A retrospective review of data for 126 patients with metastatic osteosarcoma was conducted. The study population consisted of 70 men and 56 women, with a mean age of 21 years (range: 4-75 years). The mean postmetastasis follow-up period was 37 months (range: 1-245 months).
The 5-year PMS rate was 31% and median PMS duration was 22 months. In the multivariate analyses, no metastasectomy (P < 0.001), local recurrence prior to metastasis (P = 0.016), extrapulmonary metastasis (P = 0.006), and poor histologic response to preoperative chemotherapy (P = 0.047) were significant poor prognostic factors. The 5-year PMS without any negative prognostic factor was 60.2%; with one factor, 31.6%; and with more than two factors, 3.6%.
PMS in osteosarcoma patients was influenced by primary tumor-related factors such as histologic response to chemotherapy, as well as metastasis-related factors such as complete metastasectomy and metastasis site. A certain group of patients without such poor prognostic factors could be cured even after the development of metastasis.
转移性骨肉瘤转移后生存(PMS)的预测预后因素尚不清楚。我们的目的是评估四肢高级别骨肉瘤患者的PMS,并确定与PMS相关的预后因素。
对126例转移性骨肉瘤患者的数据进行回顾性分析。研究人群包括70名男性和56名女性,平均年龄21岁(范围:4 - 75岁)。转移后的平均随访时间为37个月(范围:1 - 245个月)。
5年PMS率为31%,中位PMS持续时间为22个月。在多变量分析中,未进行转移灶切除术(P < 0.001)、转移前局部复发(P = 0.016)、肺外转移(P = 0.006)以及对术前化疗的组织学反应较差(P = 0.047)是显著的不良预后因素。无任何不良预后因素的5年PMS为60.2%;有一个因素的为31.6%;有两个以上因素的为3.6%。
骨肉瘤患者的PMS受原发性肿瘤相关因素(如对化疗的组织学反应)以及转移相关因素(如完整的转移灶切除术和转移部位)的影响。即使在发生转移后,某些没有这些不良预后因素的患者组也可能治愈。